Firefly BioWorks Announces Strategic Partnership with EMD Millipore

CAMBRIDGE, Mass. -- Firefly BioWorks announced today that it has entered into a strategic partnership with EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany. Under the terms of the agreement, EMD Millipore will lead global distribution of the Firefly™ microRNA Assay, the first product to be developed on the Firefly™ Discovery [...]

Sartorius Stedim Biotech and BD Diagnostics Strengthen Cooperation in the Area of Microbiological Diagnostics

GOETTINGEN, Germany and BALTIMORE -- Sartorius Stedim Biotech (SSB), a leading international pharma and biotech supplier, and BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a collaboration to develop, manufacture and market various ready-to-use, prefilled media products for microbiological applications in pharmaceutical, biotech [...]

OpenHelix Bioinformatics Tutorial Suites Now Available on Mobile Devices

Seattle, WA -- OpenHelix announced today of its launch of bioinformatics and genomics tutorial suites that can now run in browsers of mobile devices including those running iOS, Android, and Windows mobile operating systems as well on desktop browsers. Over 100 tutorials introduce researchers, teachers, and students to biomedical resources that are freely available on [...]

Quantum Materials Files Annual Report and Reviews Advances in Tetrapod Quantum Dot Science

SAN MARCOS, Tex. — Quantum Materials Corporation(OTCQB:QTMM) this week filed its annual report on Form 10-K for the year ended June 30, 2013 with the Securities and Exchange Commission. The annual report can be read at the “Link to SEC filings” at (https://qmcdots.com/press.html) Stephen B. Squires, Founder, President and CEO of Quantum Materials Corporation said, [...]

Kromek Group Plc – Admission and First Day of Dealings on AIM

Kromek Group Plc (AIM: KMK), a UK based technology company, developing high performance materials and products for radiation detection, is pleased to announce that its shares will today be admitted to trading on AIM. The Company has raised £15 million before expenses through the sale of new ordinary shares at a price of 51 pence [...]

OpGen and Hitachi High-Technologies Corporation Enter into an Agreement to Develop Human Chromosome Mapping Service

Gaithersburg, Md. and Tokyo — OpGen, Inc., a leading genetic analysis company, and Hitachi High-Technologies Corporation today announced an agreement to develop a comprehensive human chromosome mapping analytical service for clinical research applications by a combination of OpGen’s market-leading Whole Genome Mapping™ technology and Hitachi High-Technologies’ and Hitachi group’s cloud-based systems. This service will include [...]

MRM Proteomics and PROOF Centre Collaborate with the Jain Foundation to Identify Blood-Based Biomarkers of LGMD2B/Miyoshi Muscular Dystrophy

Vancouver, BC and Seattle, WA - The Centre of Excellence for the Prevention of Organ Failure (PROOF Centre) and MRM Proteomics Inc. will use their biomarker expertise in collaboration with the Jain Foundation, Inc. to identify blood-based biomarkers of disease in individuals with a rare form of muscular dystrophy, called Limb?girdle muscular dystrophy 2B (LGMD2B) [...]

QIAGEN Launches Empowered Genome Community, Invites Citizen Scientists and Researchers to Pool and Collaboratively Interpret Human Genomes

Redwood City, California, and Hilden, Germany -- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the Empowered Genome Community, which is a first-of-its-kind initiative to help people who have had their genomes sequenced share, explore, and interpret their data with researchers and each other. To highlight how the community can spark new biomedical [...]

GenoLogics Announces No-cost Clarity Cloud Edition

Victoria, BC, Canada –– GenoLogics Life Sciences Software, a leading provider of laboratory information management systems (LIMS) announced today the availability of three new cloud-based lab management products: Clarity Run Manager, Clarity Run Manager Plus, and the early access availability of Clarity LIMS Silver. These editions are sized and priced to fit any genomics laboratory’s [...]

Vitro Biopharma Announces Plans to Acquire & Merge with Neuromics, Inc.

Golden, Colorado -- Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, signed a non-binding letter of intent to acquire and merge with Neuromics, Inc, a privately held life-science firm located in Minneapolis, MN. The Merger would be structured as a reverse triangular merger, with Neuromics becoming a wholly-owned subsidiary of Vitro. Completion of the proposed [...]

Access IBO on Knowledge Center